Dimopoulos, M. A., Beksac, M., Benboubker, L., Roddie, H., Allietta, N., Broer, E., Couturier, C., Mazier, M.-A., Angermund, R. and Facon, T. (2013) “Phase II study of bortezomib–dexamethasone alone or with added cyclophosphamide or lenalidomide for sub-optimal response as second-line treatment for patients with multiple myeloma”, Haematologica. Pavia, Italy, 98(8), pp. 1264-1272. doi: 10.3324/haematol.2013.084376.